NEW YORK, Sept. 8, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0611074/Global-Metabolomics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics
This report analyzes the worldwide markets for Metabolomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2008 through 2017. The report profiles 45 companies including many key and niche players such as Agilent Technologies, Inc., Avogadro, BG Medicine, Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Chenomx, Inc., Human Metabolome Technologies, Inc., Metabolon, Inc., Metanomics GmbH, and SiDMAP, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
Metabolomics 3
2. INDUSTRY OVERVIEW 4
Outlook 4
Current and Future Analysis 4
Biotechnology and Pharmaceutical Sectors Drive Metabolomics
Research 4
Table 1: World Proteomics Market (2008 & 2015): Percentage
Share Breakdown by Major Product Segments - Mass
Spectrometry, Metabolomics, 2D Gel Electrophoresis and
Differential In-gel Electrophoresis (includes corresponding
Graph/Chart) 5
Metabolomics - A Handy Tool in Drug Discovery 5
Metabolomic Research - A Prospective Tool to Validate
Potential Targets 5
Bioinformatics Segment - Fastest Growing Market Segment 6
Demand for Data Analysis Tools and Software on Rise 6
Groundbreaking Successes to Propel Adoption of Metabolomics 6
Metabolomic Research - A Popular Concept in Europe 7
Food Sciences Look Up to Metabolomics 7
Metabolites Analysis in Biological Specimens Applications 7
Table 2: Global Metabolites Market (2010 & 2014): Percentage
Breakdown of Revenues in Biological Specimens Applications by
Region - North America, Europe, Asia, and Rest of World
(includes corresponding Graph/Chart) 7
Metabolite Profiling for Biomarker Discovery Applications 8
Table 3: Global Metabolite Profiling Market (2010 & 2014):
Percentage Breakdown of Revenues in Biomarker Discovery
Applications by Region - North America, Europe, Asia, and
Rest of World (includes corresponding Graph/Chart) 8
Table 4: Worldwide Oncology Biomarker Discovery Market
(2010): Percentage Share Breakdown by Major Segments-
Genetic, Imaging, Protein and Metabolomics (includes
corresponding Graph/Chart) 8
3. PRODUCT OVERVIEW 9
Metabolomics - Introduction 9
Metabolome 9
Metabolites 9
Metabolomics Vs. Metabonomics 10
Analytical Methods 10
Separation Techniques 10
Gas chromatography 10
Capillary Electrophoresis 10
High Performance Liquid Chromatography (HPLC) 10
Detection Techniques 11
Mass spectrometry 11
Nuclear Magnetic Resonance (NMR) Spectroscopy 11
Surface-based Mass Analysis 11
Key Application Areas 11
Toxicity Assessment/Toxicology 11
Functional Genomics 11
Nutrigenomics 11
Conceptual Approaches in Metabolomics 12
Target Analysis 12
Metabolite Profiling 12
Metabolomics 12
Metabolic Fingerprinting 12
Technological Advancements in Metabolomics 12
Metabolomics as Systems Biology Tool 13
Metabolomics: A Link Between Genetics and Ecology 13
Limitations 14
An Overview of Metabolomics Research 14
Adoption of Metabolomics Research by Type of Entity 14
Implementation of Metabolomics Research by Nature of Study 14
Implementation of Metabolomics Research by Type of Laboratory 14
Key Issues Associated with Metabolomics Study 14
History 15
4. PRODUCT INTRODUCTIONS/INNOVATIONS 16
Food for Health Ireland Launches New Range of Metabolomics 16
BIOCRATES Life Sciences Introduces AbsoluteIDQ p180 Kit 16
BIOCRATES Life Sciences Rolls Out MetaDisIDQ Kit 16
Agilent Technologies Rolls Out GeneSpring GX 11.5 Suite 17
Thermo Fisher Scientific Introduces Version 7.0 of Mass
Frontier Software 18
Thermo Fisher Scientific Rolls Out 'MetQuest' Automated
Metabolic Screening Software 19
Molecular Biometrics Launches ViaMetrics-ET Procedure 19
Bruker Daltonics Introduces First 18 Tesla FTMS Magnet 19
Agilent Technologies Launches 6540 UHD Q-TOF, 7700 Series ICP-
MS and 6430 Triple Quadrupole LC/MS 20
Bio-Rad Introduces Spectral Databases and KnowItAll®
Informatics System 8.1 20
Bio-Rad Laboratories Launches Spectral Databases 20
Agilent Technologies Unveils Agilent 6540 UHD Accurate-mass Q-
TOF LC/MS 21
Genedata Rolls Out Expressionist 5.2 22
Bruker Daltonics Introduces New Ion Trap amaZon Series 22
XenoTech Starts Providing Metabolite Profiling Services 22
5. RECENT INDUSTRY ACTIVITY 24
Bruker Deploys NMR Metabolic Profiling Units Systems 24
OWL Genomics Takes Over Majority Stake in MD Renal 24
Symyx Technologies Inks Partnership with Simulations Plus 24
BIOCRATES Life Sciences Joins SysKid 25
BIOCRATES Life Sciences Signs Agreement with CHENOMX 25
Stemina Biomarker Discovery Teams Up with Agilent Technologies 25
Scottish Metabolomics Facility Selects Mass Spectrometers of
Thermo Fisher Scientific 26
Syngenta Ventures Purchases Stake in Metabolon 26
Horizon Discovery Inks Agreement with GlaxoSmithKline 26
Rexahn Pharmaceuticals Signs Licensing Agreement with Teva
Pharmaceutical Industries 27
Microsoft Takes Over Rosetta Biosoftware 27
Dionex and ESA Biosciences Ink Agreement 27
Agios Pharmaceuticals Discovers New Application of IDH1 Gene
Mutation 28
6. FOCUS ON SELECT PLAYERS 29
Agilent Technologies, Inc. (US) 29
Avogadro (France) 29
BG Medicine, Inc. (US) 29
Biocrates Life Sciences AG (Austria) 30
Bio-Rad Laboratories, Inc. (US) 30
Bruker Corporation (US) 31
Chenomx, Inc. (Canada) 31
Human Metabolome Technologies, Inc. (Japan) 32
Metabolon, Inc. (US) 32
Metanomics GmbH (Germany) 33
SiDMAP, LLC (US) 33
7. GLOBAL MARKET PERSPECTIVE 34
Table 5: World Recent Past, Current and Future Analysis for
Metabolomics by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (Excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2008 through 2017 (includes corresponding
Graph/Chart) 34
Table 6: World 10-Year Perspective for Metabolomics by
Geographic Region -Percentage Breakdown of Dollar Revenues for
US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), and
Rest of World Markets for Years 2008, 2011 and 2017 (includes
corresponding Graph/Chart) 35
8. THE UNITED STATES 36
A.Market Analysis 36
Current and Future Analysis 36
Product Introductions/Innovations 36
Recent Industry Activity 42
Key Players 44
B.Market Analytics 47
Table 7: US Recent Past, Current & Future Analysis for
Metabolomics Analyzed with Annual Revenue Figures in US$
Million for Years 2008 through 2017 (includes corresponding
Graph/Chart) 47
9. CANADA 48
A.Market Analysis 48
Current and Future Analysis 48
Key Player 48
B.Market Analytics 49
Table 8: Canadian Recent Past, Current & Future Analysis for
Metabolomics Analyzed with Annual Revenue Figures in US$
Million for Years 2008 through 2017 (includes corresponding
Graph/Chart) 49
10. JAPAN 50
A.Market Analysis 50
Current and Future Analysis 50
Key Player 50
B.Market Analytics 51
Table 9: Japanese Recent Past, Current & Future Analysis for
Metabolomics Analyzed with Annual Revenue Figures in US$
Million for Years 2008 through 2017 (includes corresponding
Graph/Chart) 51
11. EUROPE 52
A.Market Analysis 52
Current and Future Analysis 52
Product Introductions/Innovations 52
Recent Industry Activity 53
B.Market Analytics 54
Table 10: European Recent Past, Current & Future Analysis
for Metabolomics by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets Independently Analyzed
with Annual Revenues in US$ Million for Years 2008 through
2017 (includes corresponding Graph/Chart) 54
Table 11: European 10-year Perspective for Metabolomics by
Geographic Region - Percentage Breakdown of Dollar Revenues
for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2008, 2011 and 2017 (includes corresponding
Graph/Chart) 55
11a. FRANCE 56
A.Market Analysis 56
Current and Future Analysis 56
Key Player 56
B.Market Analytics 57
Table 12: French Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in
US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart) 57
11b. GERMANY 58
A.Market Analysis 58
Current and Future Analysis 58
Key Player 58
B.Market Analytics 59
Table 13: German Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in
US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart) 59
11c. ITALY 60
A.Market Analysis 60
Current and Future Analysis 60
B.Market Analytics 60
Table 14: Italian Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in
US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart) 60
11d. THE UNITED KINGDOM 61
A.Market Analysis 61
Current and Future Analysis 61
B.Market Analytics 61
Table 15: UK Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in
US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart) 61
11e. REST OF EUROPE 62
A.Market Analysis 62
Current and Future Analysis 62
Product Introductions/Innovations 62
Recent Industry Activity 63
Key Player 64
B.Market Analytics 65
Table 16: Rest of Europe Recent Past, Current & Future
Analysis for Metabolomics Independently Analyzed with Annual
Revenues in US$ Million for Years 2008 through 2017
(includes corresponding Graph/Chart) 65
12. ASIA-PACIFIC 66
A.Market Analysis 66
Current and Future Analysis 66
B.Market Analytics 66
Table 17: Asia-Pacific Recent Past, Current & Future
Analysis for Metabolomics Analyzed with Annual Revenue
Figures in US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart) 66
13. REST OF WORLD 67
A.Market Analysis 67
Current and Future Analysis 67
B.Market Analytics 67
Table 18: Rest of World Recent Past, Current & Future
Analysis for Metabolomics Analyzed with Annual Revenue
Figures in US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart) 67
COMPETITIVE LANDSCAPE
Total Companies Profiled: 45 (including Divisions/Subsidiaries - 49)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 27
Canada 3
Japan 2
Europe 14
France 1
Germany 3
The United Kingdom 1
Italy 1
Spain 2
Rest of Europe 6
Asia-Pacific (Excluding Japan) 3
------------------------------------------
To order this report:
Genomics Industry: Global Metabolomics Industry
Genomics Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article